Neurosteer Bedside Monitoring System for ICU Patients
This study is testing a new brain monitoring system called Neurosteer to see how well it can track delirium, sedation, and agitation in patients who are in the intensive care unit (ICU) and on a breathing machine. The Neurosteer device is a single-channel EEG (electroencephalogram) monitor that will be placed on your forehead. Researchers want to see if the readings from this device match up with standard ways of measuring sedation (Richmond Agitation Sedation Scale or RASS) and delirium (Confusion Assessment Method for the ICU or CAM-ICU). They will also compare it to continuous EEG monitoring. The study plans to enroll 100 patients, some with brain injuries and some without, to see if the device works similarly for both groups. The goal is to find out if the Neurosteer system can be a useful tool for monitoring these conditions.
- Study design
- This is an interventional study enrolling 100 participants. All enrolled patients will receive the Neurosteer brain monitoring device.
- What's involved
- The Neurosteer device will be attached to your forehead, and readings will be collected for the duration of your NSICU stay. You will also receive Neurosteer auditory stimulation 3-4 times a day to coincide with RASS and 1-2 times a day to coincide with CAM-ICU.
- Compensation
- Not stated in the trial record.
- Follow-up
- Sedation will be measured 3-4 times daily throughout your NSICU stay, which is expected to average 14 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Neurosteer Bedside Monitoring System
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Neha S Dangayach, MD, MSCR, FNCS, FAAN, DCE'21 · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Sedation as measured by Richmond Agitation Sedation Scale3-4 times daily throughout participants NSICU stay (average 14 days)
Richmond Agitation Sedation Scale (RASS) for measuring the depth of sedation in sedated, intubated critically ill patients. RASS scoring -5 to +4, is a valid and reliable instrument to assess level of sedation and agitated behavior during sedation, where higher scores indicate higher levels of agitation. 4 Combative, violent, danger to staff 3 Pulls or removes tube(s) or catheters; aggressive 2 Frequent non-purposeful movement 1 Anxious, apprehensive, but not aggressive 0 Alert and calm 1. Awakens to voice (eye opening/contact) \>10 sec 2. Light sedation, briefly awakens to voice (eye opening/contact) \<10 sec 3. Moderate sedation, movement or eye opening. No eye contact 4. Deep sedation, no response to voice, but movement or eye opening to physical stimulation 5. Unarousable, no response to voice or physical stimulation